Activated Factor IX Complex in Treatment of Surgical Cases of Hemophilia A with Inhibitors

Summary

Three patients with severe hemophilia A with inhibitors to factor VIII were treated with activated factor IX complex. Bleeiling was controlled adequately during surgical procedures involving each of the three. Partial thromboplastin times showed a variable shortening and prothrombin times were significantly shortened to values less than normal. Hemostasis was substantiated by the use of epsilon aminocaproic acid. Neither anamnestic responses nor thrombotic complications were observed. A transient hypertension developed in two patients shortly after infusion with the activated factor IX complex.

Keywords

Autoplex - Surgical cases - Hemophilia A with inhibitors

• References

• 1 Bloom AL. Clotting factor concentrates for resistant haemophilia. Br J Haematol 1978; 40: 021-027
• 2 Mannucci PM, Federici A, Viganò S, Cattaneo M. Multiple dental extractions with a new prothrombin complex concentrate in two patients with factor VIII inhibitors. Thromb Res 1979; 15: 359-364
• 3 Abildgaard CF, Penner JA, Watson-Williams EJ. Anti-inhibitor coagulant complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia. Blood 1980; 56: 978-984
• 4 Sibley C. Center for Disease Control Thrombosis and Hemostasis Procedures III. Procedures Used in the Thrombosis and Hemostasis Laboratory. Center for Disease Control; Atlanta, GA:
• 5 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 045-052
• 6 Chi DS, Chen JP. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum. Thromb Haemostas 1976; 35: 423-436
• 7 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 8 Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies Am J Clin Pathol 1961; 36: 212-219
• 9 Quick AJ, Hussey CB, Geppert M. Prothrombin: Anayltical and clinical aspects. Comparison of the one- and two-stage methods Am J Med Sci 1963; 246: 517-526
• 10 Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, van Eys J. A more uniform measurement of factor VIII inhibitors (letter). Thrombos Diathes Haemorrh 1975; 34: 869-872
• 11 Blatt PM, Lundblad RL, Kingdon HS, McLean G, Roberts HR. Thrombogenic materials in prothrombin complex concentrates. Ann Intern Med 1974; 81: 766-770
• 12 Kasper CK. Postoperative thromboses in hemophilia B (letter). N Engl J Med 1973; 289: 160
• 13 Kasper CK. Thromboembolic complications. Thrombos Diathes Haemorr 1975; 33: 640-644
• 14 Stenbjerg S, Jørgensen J. Disseminated intravascular coagulation and infusion of factor-VHI-inhibitor bypassing activity (letter). Lancet 1977; 1: 360
• 15 Lusher JM, Soliven F, Warner AL. Management of hemophiliacs with factor VIII antibodies. Proc XT Cong World Fed Hemophilia; Tokyo: 1976. p 179
• 16 Palascak JE, Shapiro SR. Anti-factor VIII anamnesis after factor IX complex (letter). N Engl J Med 1977; 297: 1403
• 17 Kasper CK, Feinstem DI. Rising factor VIII inhibitor titers after Konỹne factor IX complex (letter). N Engl J Med 1976; 295: 505-506